Epidemiology and management of uterine fibroids
E Giuliani, S As‐Sanie, EE Marsh - International Journal of …, 2020 - Wiley Online Library
Uterine leiomyomas are one of the most common and yet understudied diseases in women.
These tumors, commonly known as fibroids, affect women mainly during their reproductive …
These tumors, commonly known as fibroids, affect women mainly during their reproductive …
[HTML][HTML] Progesterone actions and resistance in gynecological disorders
JA MacLean, K Hayashi - Cells, 2022 - mdpi.com
Estrogen and progesterone and their signaling mechanisms are tightly regulated to maintain
a normal menstrual cycle and to support a successful pregnancy. The imbalance of estrogen …
a normal menstrual cycle and to support a successful pregnancy. The imbalance of estrogen …
[HTML][HTML] Endometriosis and medical therapy: from progestogens to progesterone resistance to GnRH antagonists: a review
J Donnez, MM Dolmans - Journal of Clinical Medicine, 2021 - mdpi.com
Background: The first objective of this review was to present, based on recent literature, the
most frequently applied medical options (oral contraceptive pills (OCPs) and progestogens) …
most frequently applied medical options (oral contraceptive pills (OCPs) and progestogens) …
[HTML][HTML] Uterine fibroids: burden and unmet medical need
A Al-Hendy, ER Myers, E Stewart - Seminars in reproductive …, 2017 - thieme-connect.com
Uterine fibroids affect a wide cross-section of the population, with prevalence, symptom
severity, and overall disease burden generally higher among black women, likely due to …
severity, and overall disease burden generally higher among black women, likely due to …
Treatment of uterine fibroid symptoms with relugolix combination therapy
A Al-Hendy, AS Lukes, AN Poindexter III… - … England Journal of …, 2021 - Mass Medical Soc
Background Uterine fibroids are a common cause of heavy menstrual bleeding and pain.
Treatment with the combination of relugolix (an oral gonadotropin-releasing hormone …
Treatment with the combination of relugolix (an oral gonadotropin-releasing hormone …
[HTML][HTML] Uterine fibroids and infertility
D Freytag, V Günther, N Maass, I Alkatout - Diagnostics, 2021 - mdpi.com
Infertility is a disease of the reproductive system defined by the failure to achieve a clinical
pregnancy after 12 months or more of regular unprotected sexual intercourse. Uterine …
pregnancy after 12 months or more of regular unprotected sexual intercourse. Uterine …
Elagolix for heavy menstrual bleeding in women with uterine fibroids
WD Schlaff, RT Ackerman, A Al-Hendy… - … England Journal of …, 2020 - Mass Medical Soc
Background Uterine fibroids are hormone-responsive neoplasms that are associated with
heavy menstrual bleeding. Elagolix, an oral gonadotropin-releasing hormone antagonist …
heavy menstrual bleeding. Elagolix, an oral gonadotropin-releasing hormone antagonist …
Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials
Background Uterine fibroids are common non-cancerous neoplasm that cause heavy
menstrual bleeding and other signs. Linzagolix is an oral gonadotropin-releasing hormone …
menstrual bleeding and other signs. Linzagolix is an oral gonadotropin-releasing hormone …
[HTML][HTML] Uterine fibroids and diet
A Tinelli, M Vinciguerra, A Malvasi, M Andjić… - International journal of …, 2021 - mdpi.com
Uterine myomas or fibroids are the most common benign female tumors of the reproductive
organs, associated with significant morbidity and quality of life impairment. Several …
organs, associated with significant morbidity and quality of life impairment. Several …
Uterine stem cells: from basic research to advanced cell therapies
X Santamaria, A Mas, I Cervelló… - Human Reproduction …, 2018 - academic.oup.com
BACKGROUND Stem cell research in the endometrium and myometrium from animal
models and humans has led to the identification of endometrial/myometrial stem cells and …
models and humans has led to the identification of endometrial/myometrial stem cells and …